ATE362943T1 - Zusammensetzungen enthaltend chitosan in der form von nanofasern - Google Patents

Zusammensetzungen enthaltend chitosan in der form von nanofasern

Info

Publication number
ATE362943T1
ATE362943T1 AT02792233T AT02792233T ATE362943T1 AT E362943 T1 ATE362943 T1 AT E362943T1 AT 02792233 T AT02792233 T AT 02792233T AT 02792233 T AT02792233 T AT 02792233T AT E362943 T1 ATE362943 T1 AT E362943T1
Authority
AT
Austria
Prior art keywords
compositions
care
nanofibers
compositions containing
containing chitosan
Prior art date
Application number
AT02792233T
Other languages
English (en)
Inventor
Gordon Robert Davison
Axel Konig
Clyde Gibbons
Mark Brian Ripley
Neil Archibald Macgilp
Georgina Lyndsey Claire Milich
Emma Louise Pretswell
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE362943T1 publication Critical patent/ATE362943T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/027—Fibers; Fibrils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A61Q11/02—Preparations for deodorising, bleaching or disinfecting dentures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
AT02792233T 2001-11-09 2002-11-08 Zusammensetzungen enthaltend chitosan in der form von nanofasern ATE362943T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0126923.2A GB0126923D0 (en) 2001-11-09 2001-11-09 Chitosan compositions

Publications (1)

Publication Number Publication Date
ATE362943T1 true ATE362943T1 (de) 2007-06-15

Family

ID=9925463

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02792233T ATE362943T1 (de) 2001-11-09 2002-11-08 Zusammensetzungen enthaltend chitosan in der form von nanofasern

Country Status (9)

Country Link
US (1) US6638918B2 (de)
EP (1) EP1442066B1 (de)
JP (1) JP2005509059A (de)
AT (1) ATE362943T1 (de)
CA (1) CA2466654C (de)
DE (1) DE60220306T2 (de)
ES (1) ES2287347T3 (de)
GB (1) GB0126923D0 (de)
WO (1) WO2003042251A1 (de)

Families Citing this family (117)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
US6740752B2 (en) * 2000-05-12 2004-05-25 The Procter & Gamble Company Process for preparing chitosan particles
US6972010B2 (en) * 2001-04-17 2005-12-06 The Procter & Gamble Company Absorbent article comprising an agent able to convey a perception to the wearer, without the need to create the external condition perceived
KR20040058325A (ko) * 2001-11-26 2004-07-03 유겐가이샤 오까다 기껜 소취제 및 이를 함유하는 세발 화장료
BE1014638A6 (fr) * 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
EP1384404A1 (de) * 2002-07-23 2004-01-28 The Procter & Gamble Company Haarpflegemittel
US8409618B2 (en) 2002-12-20 2013-04-02 Kimberly-Clark Worldwide, Inc. Odor-reducing quinone compounds
US7666410B2 (en) 2002-12-20 2010-02-23 Kimberly-Clark Worldwide, Inc. Delivery system for functional compounds
US7582308B2 (en) 2002-12-23 2009-09-01 Kimberly-Clark Worldwide, Inc. Odor control composition
CA2534483A1 (en) * 2003-09-19 2005-03-31 Hill's Pet Nutrition, Inc. Composition and method for treating bezoar and trichobezoar
US7837663B2 (en) 2003-10-16 2010-11-23 Kimberly-Clark Worldwide, Inc. Odor controlling article including a visual indicating device for monitoring odor absorption
US7438875B2 (en) 2003-10-16 2008-10-21 Kimberly-Clark Worldwide, Inc. Method for reducing odor using metal-modified silica particles
US7488520B2 (en) 2003-10-16 2009-02-10 Kimberly-Clark Worldwide, Inc. High surface area material blends for odor reduction, articles utilizing such blends and methods of using same
US7754197B2 (en) 2003-10-16 2010-07-13 Kimberly-Clark Worldwide, Inc. Method for reducing odor using coordinated polydentate compounds
US7141518B2 (en) 2003-10-16 2006-11-28 Kimberly-Clark Worldwide, Inc. Durable charged particle coatings and materials
US7794737B2 (en) * 2003-10-16 2010-09-14 Kimberly-Clark Worldwide, Inc. Odor absorbing extrudates
US7413550B2 (en) 2003-10-16 2008-08-19 Kimberly-Clark Worldwide, Inc. Visual indicating device for bad breath
US7879350B2 (en) 2003-10-16 2011-02-01 Kimberly-Clark Worldwide, Inc. Method for reducing odor using colloidal nanoparticles
US7582485B2 (en) 2003-10-16 2009-09-01 Kimberly-Clark Worldride, Inc. Method and device for detecting ammonia odors and helicobacter pylori urease infection
US7678367B2 (en) 2003-10-16 2010-03-16 Kimberly-Clark Worldwide, Inc. Method for reducing odor using metal-modified particles
CA2545157A1 (en) * 2003-11-11 2005-05-19 Veckis Industries Ltd. Disinfecting composition and methods of making and using same
BRPI0416722A (pt) * 2003-12-23 2007-01-16 Unilever Nv barreira comestìvel, produto alimentìcio composto, produto alimentìcio e processo para a preparação de um produto alimentìcio
US20050142965A1 (en) * 2003-12-29 2005-06-30 Kimberly-Clark Worldwide, Inc. Surface charge manipulation for improved fluid intake rates of absorbent composites
US20050196497A1 (en) * 2004-03-03 2005-09-08 Kraft Foods Holdings, Inc. Antimicrobial effect of chitosan in beverages
WO2005087280A1 (en) * 2004-03-11 2005-09-22 Medtrade Products Limited Compositions of alpha and beta chitosan and methods of preparing them
US7740883B2 (en) * 2004-03-28 2010-06-22 University Of Debrecen Nanoparticles from chitosan
US7163579B2 (en) * 2004-04-14 2007-01-16 H.B. Fuller Licensing & Financing Inc. Method of making water resistant corrugated boards
JP2007536259A (ja) * 2004-05-06 2007-12-13 イヴレア ファーマスーティカルズ インコーポレイテッド 活性薬剤の送達のための粒子
US20050283004A1 (en) * 2004-06-18 2005-12-22 Hopax Chemicals Manufacturing Co., Ltd. Alkylsulfonated polyaminosaccharides
US8652456B2 (en) * 2004-06-21 2014-02-18 Basf Se Aqueous preparations comprising at least one water-soluble or water-dispersible copolymer with cationgenic groups
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7611695B2 (en) * 2004-11-15 2009-11-03 Ultradent Products, Inc. Flavored hemostatic and acid etching compositions
US20090076168A1 (en) * 2005-03-04 2009-03-19 Tien Canh Le Amine-based and imine-based polymers, uses and preparation thereof
US8308075B2 (en) 2005-04-19 2012-11-13 Kamterter Products, Llc Systems for the control and use of fluids and particles
US7536962B2 (en) * 2005-04-19 2009-05-26 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles
US7311050B2 (en) * 2005-04-19 2007-12-25 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles
DE102005048776A1 (de) * 2005-10-07 2007-04-12 Beiersdorf Ag Desodorierende Reinigungszubereitung
ITRM20050585A1 (it) * 2005-11-23 2007-05-24 Mavi Sud S R L Nanofibrille di chitina spray-dried, metodo di produzione ed usi.
FR2894809B1 (fr) * 2005-12-15 2008-03-21 Oreal Composition cosmetique comprenant une dispersion aqueuse de particules colloidales de charge minerale et des fibres
US7977103B2 (en) 2006-04-20 2011-07-12 Kimberly-Clark Worldwide, Inc. Method for detecting the onset of ovulation
DE102006020035A1 (de) * 2006-04-26 2007-10-31 B. Braun Melsungen Ag Herstellung und Verwendung von Poly(hydroxyethylstärke)chitin- und Poly(Carboxymethylstärke)chitin-Verbindungen
FR2902799B1 (fr) 2006-06-27 2012-10-26 Millipore Corp Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
US20080072494A1 (en) * 2006-09-07 2008-03-27 Stoner Richard J Micronutrient elicitor for treating nematodes in field crops
US8623842B2 (en) 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
US20110229534A1 (en) * 2006-10-05 2011-09-22 The Trustees Of Columbia University In The City Of New York Non-Irritating Oral Care Formulations
US20080114096A1 (en) * 2006-11-09 2008-05-15 Hydromer, Inc. Lubricious biopolymeric network compositions and methods of making same
US8569464B2 (en) 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
US8163886B2 (en) * 2006-12-21 2012-04-24 Emd Millipore Corporation Purification of proteins
EP1958639A1 (de) 2007-02-14 2008-08-20 Polichem S.A. Verwendung von Chitosanen zur Behandlung von Entzündungserkrankungen der Nägel
ES2918452T3 (es) 2007-02-19 2022-07-15 Marine Polymer Tech Inc Composiciones hemostáticas y regímenes terapéuticos
WO2008135957A2 (en) 2007-05-07 2008-11-13 Koninklijke Philips Electronics N.V. A method for cleaning dental plaque from teeth using an adherent peelable gel
CZ2007716A3 (cs) 2007-10-15 2009-04-29 Elmarco S. R. O. Zpusob výroby nanovláken
TW200928022A (en) * 2007-12-31 2009-07-01 Acelon Chem & Fiber Corp Manufacturing method for natural cellulose fiber with increased mildew-proof, antibacterial and deodorizing functions
TWI441641B (zh) * 2007-12-31 2014-06-21 Preparation of chitosan with ultra - fine nano - modification
US9061087B2 (en) * 2008-03-04 2015-06-23 Hemostasis, Llc Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
US7943597B2 (en) * 2008-04-08 2011-05-17 Cypress Pharmaceutical, Inc. Phosphate-binding chitosan and uses thereof
WO2009151514A1 (en) * 2008-06-11 2009-12-17 Millipore Corporation Stirred tank bioreactor
EP2153836A1 (de) 2008-08-04 2010-02-17 Polichem S.A. Filmbildende flüssige Formulierungen zur Wirkstofffreisetzung im Haar und auf der Kopfhaut
EP2116237A1 (de) 2008-08-05 2009-11-11 Polichem SA Zusammensetzungen enthaltend Chitosan und Dicarboxysäure zur Behandlung von Rosacea
JP4333966B1 (ja) * 2008-08-29 2009-09-16 株式会社データアクション 入浴剤及び浴湯
DK2370561T3 (da) * 2008-12-16 2019-10-21 Emd Millipore Corp Omrøringstankreaktor og fremgangsmåde
EP2266546A1 (de) 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Verfahren zur Herstellung kolloidaler Systeme zur Abgabe von Wirkstoffen
US20110052663A1 (en) * 2009-09-01 2011-03-03 Hemostasis, Llc Hemostatic Sponge with Enzyme and Method of Manufacture
PH12012501879A1 (en) * 2010-03-22 2019-07-10 Water Security Corp Filter comprising a halogen release system and chitosan
US9309435B2 (en) 2010-03-29 2016-04-12 The Clorox Company Precursor polyelectrolyte complexes compositions comprising oxidants
US9474269B2 (en) 2010-03-29 2016-10-25 The Clorox Company Aqueous compositions comprising associative polyelectrolyte complexes (PEC)
US20110236582A1 (en) 2010-03-29 2011-09-29 Scheuing David R Polyelectrolyte Complexes
NZ703163A (en) 2010-04-15 2016-06-24 Marinepolymer Tech Inc Anti-bacterial applications of poly-n-acetylglucosamine nanofibers
CN102892791B (zh) 2010-05-17 2017-05-17 Emd密理博公司 用于纯化生物分子的刺激响应性聚合物
WO2012036283A1 (ja) * 2010-09-16 2012-03-22 国立大学法人鳥取大学 キチンナノファイバーまたはキトサンナノファイバーを含む化粧料、入浴剤および医薬組成物
CN103282024A (zh) * 2010-11-06 2013-09-04 海洋聚合物技术公司 用于纳米聚合物基核酸递送的组合物和方法
MX344362B (es) 2011-02-18 2016-12-14 Gaba Int Holding Ag Composicion de enjuague bucal.
RU2013142576A (ru) * 2011-02-18 2015-05-10 Габа Интернациональ Холдинг Аг Композиция средства для чистки зубов
WO2012119155A1 (en) * 2011-03-03 2012-09-07 American Dental Association Foundation Antimicrobial compositions for tooth fluoridation and remineralization
EP2696680B1 (de) 2011-04-15 2018-11-28 Marine Polymer Technologies, Inc. Behandlung von hsv infektionen mit poly-n-acetyl-glucosamin-nanofasern
CN102504352B (zh) * 2011-11-03 2013-12-25 华南理工大学 一种羧甲基壳寡糖季铵盐/累托石纳米复合材料及其制备方法与应用
TWI419701B (zh) * 2011-11-08 2013-12-21 包覆生長因子之多醣體微粒子
US20140186273A1 (en) * 2012-12-27 2014-07-03 University Of Southern California Chitosan -Amelogenin Hydrogel for In Situ Enamel Growth
KR101457789B1 (ko) * 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
PE20160473A1 (es) 2013-05-29 2016-05-22 Aguas De Manizales S A E S P Composiciones para tratamiento de aguas y metodos para uso de las mismas
CN103319750B (zh) * 2013-06-13 2016-10-05 华南理工大学 一种羧甲基壳聚糖季铵盐/改性磷酸锆纳米复合材料
DE102013211519A1 (de) * 2013-06-19 2015-01-08 Henkel Ag & Co. Kgaa Mund- und Zahnpflege- und -reinigungsmittel zur Verringerung der Wiederanfärbung von Zähnen
BR112015032338A2 (pt) 2013-06-27 2017-07-25 Procter & Gamble composições e artigos para cuidados pessoais
EA201690565A1 (ru) 2013-10-23 2016-10-31 Юнилевер Н.В. Антиперспирантная композиция
US8975220B1 (en) 2014-08-11 2015-03-10 The Clorox Company Hypohalite compositions comprising a cationic polymer
FR3035798B1 (fr) 2015-05-07 2017-04-28 Ifp Energies Now Particules spheroidales d'alumine de resistance mecanique amelioree ayant un diametre median macroporeux compris entre 0,05 et 30 μm.
CL2015001254A1 (es) * 2015-05-08 2015-09-11 Cyra Consultora Limitada Composición quelante de arsénico.
CL2015001532A1 (es) * 2015-06-05 2015-12-28 Fundación Copec Universidad Católica Nanofibras de quitosano contenedoras de compuestos bioactivos
US9962465B2 (en) 2015-07-07 2018-05-08 University Of Southern California Amelogenin-chitosan hydrogel for dentin hypersensitivity
KR102130319B1 (ko) * 2015-08-19 2020-07-09 (주) 에이치엔에이파마켐 천연 유래 다당류를 이용한 마이크로 섬유의 제조 방법 및 이에 의해 제조된 마이크로 섬유를 포함하는 화장료 조성물
JP6577332B2 (ja) * 2015-10-29 2019-09-18 旭化成株式会社 抗菌性能に優れた抗菌性合成繊維布帛
CA3001437A1 (en) * 2015-11-09 2017-05-18 Unilever Plc Anti-perspirant composition
BR112019006338B1 (pt) * 2016-09-30 2021-10-19 L'oreal Composição cosmética capilar e método de tratamento de cabelos
CZ2016688A3 (cs) * 2016-11-03 2017-12-20 Nano Medical s.r.o. Způsob vytvoření nanovlákenné vrstvy a textilní kompozit obsahující nanovlákennou vrstvu vytvořenou tímto způsobem
WO2018099931A1 (en) 2016-12-01 2018-06-07 Unilever Plc Anti-perspirant composition comprising chitosan
JP6896267B2 (ja) * 2017-04-06 2021-06-30 国立研究開発法人産業技術総合研究所 多孔質体及びその製造方法
US20210052472A1 (en) 2017-12-29 2021-02-25 Gaba International Holding Gmbh Dentifrice Composition
JP7083131B2 (ja) * 2018-01-25 2022-06-10 国立大学法人鳥取大学 発毛および育毛促進剤
JP7234007B2 (ja) * 2019-03-29 2023-03-07 株式会社ナリス化粧品 皮膚外用剤
CN111892667B (zh) * 2019-04-30 2024-02-20 苏州大学 含氟化合物修饰的阳离子聚合物在制备医疗美容及保健品中的应用
GB201909271D0 (en) * 2019-06-27 2019-08-14 Univ Cork Method for producing porous graphene or porous graphtic carbon
KR102231747B1 (ko) * 2019-10-16 2021-03-24 대경대학교 산학협력단 보색샴푸 조성물 및 이의 제조방법
KR102503193B1 (ko) * 2019-11-04 2023-02-23 주식회사 엔도비전 버섯 또는 진균 유래 키토산, 또는 그 유도체를 이용한 하이드로겔 및 그 제조방법
CN111213632B (zh) * 2019-11-19 2022-03-01 长春中医药大学 动物药环氧树脂标本制作方法
KR102541470B1 (ko) * 2020-11-23 2023-06-07 주식회사 유에이치에스 버섯 유래 키토산을 이용한 가축 및 반려동물용 음수첨가제 및 이의 제조방법
CN112675096B (zh) * 2021-01-22 2022-11-08 上海加新生物科技有限公司 一种抑菌杀菌植物复合组合物及其制备方法
BR112023022797A2 (pt) * 2021-05-20 2024-01-16 Ims Trading Llc Produto mastigável de animal incluindo microporos preenchidos com quitosana e método para formar um produto mastigável de animal microporoso
JP7828056B2 (ja) * 2021-06-10 2026-03-11 ピアス株式会社 口腔内病原細菌のバイオフィルム形成抑制剤、及び、口腔用製剤
KR102661511B1 (ko) * 2021-10-20 2024-04-26 서울대학교산학협력단 키토산 담체 합성 장치 및 방법
JP7747881B2 (ja) * 2021-11-01 2025-10-01 ティー．エフ．エイチ．パブリケーションズ、インコーポレーテッド キトサンを含有するペット用ガム
CN114874039A (zh) * 2022-05-18 2022-08-09 普洱学院 一种咖啡果皮有机肥料及其制备方法
CN119789873A (zh) * 2022-06-29 2025-04-08 11584022加拿大有限公司 用于药物递送的生物聚合物制剂
CN115475257A (zh) * 2022-08-29 2022-12-16 广州市一杰医药科技有限公司 一种医用超声耦合剂及制备方法
FR3147104B1 (fr) * 2023-03-30 2025-12-05 Lvmh Rech Composition cosmétique comprenant un mélange élastique à base de chitosane
CN117503635A (zh) * 2023-11-07 2024-02-06 沃美时代(深圳)生物科技有限公司 一种两性糖脂生物表面活性剂的抗菌洗发水
CN120514910B (zh) * 2025-07-07 2026-03-20 珠海市雅莎医疗器械有限公司 一种含高浓度乳酸的医用敷料及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6262827A (ja) * 1985-09-12 1987-03-19 Fuji Boseki Kk 超微小球状キトサンの製造方法
JPH02135134A (ja) 1988-11-16 1990-05-24 Katokichi:Kk 水・アルコール混合液分離用膜
JPH09249541A (ja) 1996-03-15 1997-09-22 Fudo Kosan:Kk 歯磨剤
JP2002536392A (ja) 1999-02-09 2002-10-29 コグニス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト ナノスケールのキトサンおよび／またはキトサン誘導体の使用
DE19911041A1 (de) 1999-03-12 2000-09-14 Henkel Kgaa Mit Nanopartikel-Dispersionen ausgerüstete, flexible und saugfähige Träger zur Behandlung der Haut
CA2379909C (en) 1999-08-06 2011-01-04 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
PL189890B1 (pl) 1999-09-14 2005-10-31 Kazmierski Jan Zaklad Prod Usl Preparat do ochrony roślin przed chorobami
FR2799647B1 (fr) 1999-10-15 2001-12-07 Oreal Composition sous forme d'emulsion eau-dans-huile, contenant des fibres, et son utilisation dans le domaine cosmetique
DE19952073A1 (de) 1999-10-29 2001-07-12 Cognis Deutschland Gmbh Verfahren zur Herstellung von nanopartikulären Chitosanen oder Chitosan-Derivaten
DE10014529A1 (de) * 2000-03-23 2001-09-27 Cognis Deutschland Gmbh Desodorierende Zubereitungen mit nanoskaligen Chitosanen und/oder Chitosanderivaten
PL340132A1 (en) 2000-05-12 2001-11-19 Procter & Gamble Method of obtaining modified microcrystalline chitosamine
EP1243688A1 (de) 2001-03-22 2002-09-25 Cognis Iberia, S.L. Verwendung von Chitosan-Nanopartikeln

Also Published As

Publication number Publication date
DE60220306D1 (de) 2007-07-05
DE60220306T2 (de) 2008-01-17
EP1442066B1 (de) 2007-05-23
EP1442066A1 (de) 2004-08-04
CA2466654C (en) 2009-03-31
CA2466654A1 (en) 2003-05-22
US20030104020A1 (en) 2003-06-05
GB0126923D0 (en) 2002-01-02
US6638918B2 (en) 2003-10-28
WO2003042251A1 (en) 2003-05-22
JP2005509059A (ja) 2005-04-07
ES2287347T3 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
DE60220306D1 (de) Zusammensetzungen enthaltend chitosan in der form von nanofasern
RU2000119159A (ru) Микропористые пленки, включающие флокированные волокна
DK1438081T3 (da) Medicinsk transplantatanordning med mesh mönstret struktur
PT1315771E (pt) Material biologicamente activo
HUP0102899A2 (hu) Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek alsó légutakba történő beadására szolgáló készítmények előállítására
US8580362B2 (en) Silicone products and methods for making silicone products
ATE217197T1 (de) Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
DE69821655D1 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
US20040062798A1 (en) Exothermic article and the use thereof in whitening teeth
US20040163649A1 (en) Disposable face mask with skin-care face-contacting layer
KR20040085646A (ko) 상처치료용 드레싱 또는 팩제로 이용할 수 있는 수화겔드레싱 및 그의 제조방법
DE50107692D1 (de) Verwendung von selenithältigen wässerigen lösungen zur herstellung eines medikaments zur behandlung viraler erkrankungen und pigmentflecken
ATE191342T1 (de) Verwendung von riluzol zur behandlung mitochondrialer erkrankungen
DE60128911D1 (de) Verwendung von l-threo-methylphenidat zur herstellung eines medikamentes zur behandlung von psychischen erkrankungen
JPH1037070A (ja) 緑茶成分カテキン含有抗菌繊維
CN2728488Y (zh) 甲壳素面膜
KR20040040216A (ko) 피부보습 및 살균력을 갖는 미용팩
CN104510643A (zh) 一种睡莲根草本提取物保湿洗手液
KR200308368Y1 (ko) 자연건강 패드
Mustafi et al. Clinical efficacy of a monofilament fibre containing wound debridement product evaluated in multicentre real life study [poster]
DE60128130D1 (de) Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie a
RU61556U1 (ru) Ферментный иммуномодулирующий антибактериальный перфоративный атравматический лейкопластырь
CN100563486C (zh) 一种地榆药物纸手帕
KR20110127293A (ko) 기능성 바이오 필름을 내장시킨 마스크 안대.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties